Follow
Scott Ayton, PhD
Scott Ayton, PhD
Florey Institute of Neuroscience and Mental Health
Verified email at unimelb.edu.au
Title
Cited by
Cited by
Year
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
P Lei, S Ayton, DI Finkelstein, L Spoerri, GD Ciccotosto, DK Wright, ...
Nature medicine 18 (2), 291-295, 2012
6602012
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
QZ Tuo, P Lei, KA Jackman, XL Li, H Xiong, ZY Liuyang, L Roisman, ...
Molecular psychiatry 22 (11), 1520-1530, 2017
6182017
Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases
D Furtado, M Björnmalm, S Ayton, AI Bush, K Kempe, F Caruso
Advanced materials 30 (46), 1801362, 2018
6012018
Current state of Alzheimer’s fluid biomarkers
JL Molinuevo, S Ayton, R Batrla, MM Bednar, T Bittner, J Cummings, ...
Acta neuropathologica 136, 821-853, 2018
5612018
A delicate balance: Iron metabolism and diseases of the brain
D Hare, S Ayton, A Bush, P Lei
Frontiers in aging neuroscience 5, 34, 2013
4602013
Metallostasis in Alzheimer's disease
S Ayton, P Lei, AI Bush
Free Radical Biology and Medicine 62, 76-89, 2013
4012013
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
L Mahoney-Sánchez, H Bouchaoui, S Ayton, D Devos, JA Duce, ...
Progress in neurobiology 196, 101890, 2021
3692021
Ferroptosis and cell death mechanisms in Parkinson's disease
SJ Guiney, PA Adlard, AI Bush, DI Finkelstein, S Ayton
Neurochemistry international 104, 34-48, 2017
3432017
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
3272015
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
S Ayton, Y Wang, I Diouf, JA Schneider, J Brockman, MC Morris, AI Bush
Molecular psychiatry 25 (11), 2932-2941, 2020
3262020
The essential elements of Alzheimer’s disease
P Lei, S Ayton, AI Bush
Journal of Biological Chemistry 296, 2021
2882021
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
S Ayton, P Lei, JA Duce, BXW Wong, A Sedjahtera, PA Adlard, AI Bush, ...
Annals of neurology 73 (4), 554-559, 2013
2832013
Iron and Alzheimer’s disease: an update on emerging mechanisms
DJR Lane, S Ayton, AI Bush
Journal of Alzheimer's Disease 64 (s1), S379-S395, 2018
2732018
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ...
Brain 140 (8), 2112-2119, 2017
2642017
Tau protein: relevance to Parkinson's disease
P Lei, S Ayton, DI Finkelstein, PA Adlard, CL Masters, AI Bush
The international journal of biochemistry & cell biology 42 (11), 1775-1778, 2010
2632010
GSK‐3 in neurodegenerative diseases
P Lei, S Ayton, AI Bush, PA Adlard
International journal of Alzheimer’s disease 2011 (1), 189246, 2011
1962011
Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion
Q Tuo, Y Liu, Z Xiang, HF Yan, T Zou, Y Shu, X Ding, J Zou, S Xu, F Tang, ...
Signal transduction and targeted therapy 7 (1), 59, 2022
1942022
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
LW Hung, VL Villemagne, L Cheng, NA Sherratt, S Ayton, AR White, ...
Journal of Experimental Medicine 209 (4), 837-854, 2012
1912012
Nigral iron elevation is an invariable feature of Parkinson’s disease and is a sufficient cause of neurodegeneration
S Ayton, P Lei
BioMed research international 2014 (1), 581256, 2014
1722014
Motor and cognitive deficits in aged tau knockout mice in two background strains
P Lei, S Ayton, S Moon, Q Zhang, I Volitakis, DI Finkelstein, AI Bush
Molecular neurodegeneration 9, 1-12, 2014
1622014
The system can't perform the operation now. Try again later.
Articles 1–20